UBS Keeps Neutral Rating on Stem (STEM)
UBS Coverage and Price Forecast: UBS has maintained a Neutral recommendation for Stem (NYSE:STEM) as of October 31, 2025, with an average one-year price target of $14.96/share, indicating an 11.69% downside from its latest closing price of $16.94/share.
Projected Revenue and EPS: Stem's projected annual revenue is expected to reach $1,203 million, reflecting a significant increase of 629.32%, while the projected annual non-GAAP EPS is -0.17.
Fund Sentiment and Ownership: There has been a notable increase in institutional interest in Stem, with 113 funds reporting positions, a 653.33% increase in ownership over the last quarter, and total shares owned by institutions rising by 39,583.27% to 1,724K shares.
Shareholder Holdings: Key shareholders include Vanguard Total Stock Market Index Fund (2.90% ownership), Vanguard Extended Market Index Fund (1.48%), Bank of America (1.27%), Susquehanna International Group (1.20%), and Geode Capital Management (1.02%).
Trade with 70% Backtested Accuracy
Analyst Views on STEM
About STEM
About the author

- Strategic Transformation: LIXTE Biotechnology has entered into a merger agreement with NOMAD, transforming into a company focused on deployable power solutions, with the transaction expected to close on July 1, 2026, marking a significant shift in corporate strategy.
- Pre-Closing Investment: Prior to the deal's completion, LIXTE has loaned NOMAD $6.5 million to support the procurement of long-lead components and scale manufacturing, demonstrating management's strong confidence in market demand.
- Market Opportunity: NOMAD achieved approximately 175% year-over-year revenue growth in 2025, with projections of an additional 135% growth in 2026, and about 75% of its sales activities are driven by inbound customer inquiries, indicating robust demand in the rapidly expanding power market.
- Industry Challenges: As AI infrastructure expands rapidly, electricity demand is surging, outpacing the traditional grid's capacity; NOMAD's mobile power solutions are crucial in addressing this bottleneck, highlighting significant strategic implications for the market.
- Strategic Transformation: LIXTE Biotechnology Holdings has entered into a merger agreement with NOMAD, planning to rename itself NOMAD Power Solutions, focusing on addressing the urgent power needs of AI infrastructure, with the transaction expected to close on July 1, 2026.
- Pre-Closing Investment: Before the deal closes, LIXTE has loaned $6.5 million to NOMAD to support the procurement of long-lead components and meet the growing order demand, demonstrating management's strong confidence in market needs.
- Market Opportunity: NOMAD achieved approximately 175% revenue growth in 2025, with an expected additional 135% growth in 2026, and about 75% of sales activities are initiated by customers, indicating its leading position in the rapidly expanding power market.
- Technological Advantage: NOMAD's mobile battery energy storage systems (BESS) can be deployed quickly to meet the immediate high-quality power demands of data centers, circumventing the time and approval bottlenecks associated with traditional power infrastructure construction.

- Company Repositioning: LIXTE Biotechnology has entered into a merger agreement with NOMAD, renaming itself NOMAD Power Solutions, Inc., which signifies a major strategic shift towards addressing the AI-driven power demand crisis.
- Pre-Closing Financial Support: LIXTE will provide NOMAD with a $6.5 million loan before the transaction closes to fund long-lead component procurement and working capital, ensuring customer demand is met ahead of the merger.
- Market Leadership: NOMAD is a market leader in deployable utility-grade battery energy storage systems, with projected revenue growth of approximately 175% in 2025 and an additional 135% in 2026, indicating strong market demand and growth potential.
- Addressing Power Bottlenecks: As AI infrastructure demand for electricity surges, NOMAD's deployable storage solutions provide fast and reliable power to data centers, filling the gap left by traditional grids, which holds significant strategic market implications.
- Company Repositioning: LIXTE Biotechnology Holdings has entered into a definitive agreement to merge with NOMAD, rebranding as NOMAD Power Solutions, Inc., focusing on addressing the power shortages of the AI era, with the transaction expected to close on July 1, 2026.
- Pre-Closing Financial Support: LIXTE will provide NOMAD with a $6.5 million loan before the deal closes to fund long-lead component procurement and working capital, demonstrating management's confidence in NOMAD's market potential.
- Market Leadership: NOMAD is a leader in deployable utility-grade battery energy storage systems, reporting approximately 175% revenue growth in 2025, with an additional projected growth of 135% in 2026, indicating strong market demand and customer interest.
- Addressing Power Bottlenecks: As AI infrastructure drives surging electricity demand, NOMAD's deployable storage solutions offer rapid and reliable power supply to data centers, effectively filling the gaps that traditional grids cannot meet.
- Power Supply Challenge: Approximately 2.3 terawatts of generation and storage capacity are currently in U.S. interconnection queues, with the time to develop new capacity extending from two years to five to seven years, highlighting the urgency and investment opportunity in power supply.
- Strategic Acquisition: LIXTE Biotechnology Holdings has announced the acquisition of NOMAD Transportable Power Systems, intending to rename itself NOMAD Power Solutions, which emphasizes its commitment to the power availability market and innovative solutions.
- Market Growth Potential: NOMAD's mobile battery systems can bypass the complex approval processes of traditional power projects, which is expected to drive rapid growth in the North American market, with management projecting a revenue increase of approximately 175% year-over-year in 2025.
- Competitive Advantage: NOMAD's transportable systems provide a significant competitive edge in regions where battery storage projects face restrictions, enabling quick deployment to meet urgent customer power needs, positioning the company as a key player in emerging power infrastructure.
- Power Supply Bottleneck: Approximately 2.3 terawatts of generation and storage capacity are currently in U.S. interconnection queues, with development timelines extending to 5-7 years, highlighting power availability as a significant economic challenge for the next decade.
- Strategic Transformation: LIXTE Biotechnology has announced its acquisition of NOMAD Transportable Power Systems, intending to rename itself NOMAD Power Solutions, which emphasizes the company's commitment to the rapidly growing power availability market.
- Market Opportunity: NOMAD's mobile power systems can bypass multiple regulatory hurdles faced by traditional battery storage projects, with projected revenue growth of about 175% in 2026 and over 285% in 2027, indicating strong market demand.
- Competitive Advantage: NOMAD's system is viewed as an emerging power-as-a-service model that can be deployed quickly to meet urgent electricity needs, positioning it as a key player in the upcoming infrastructure cycle.








